Renal transplantationplus hematopoietic stem cell transplantation as Induction therapy :a single-center 10-year experience
10.3760/cma.j.issn.0254-1785.2019.05.007
- VernacularTitle:同一供者来源亲属活体肾移植联合造血干细胞移植诱导免疫耐受
- Author:
Xuanchuan WANG
1
;
Linkun HU
;
Zheng WEI
;
Qunye TANG
;
Bing CHEN
;
Zhaochong ZENG
;
Yuan JI
;
Ming XU
;
Ruiming RONG
;
Tongyu ZHU
Author Information
1. 复旦大学附属中山医院泌尿外科 上海市器官移植重点实验室 200032
- Keywords:
Living donor;
Kidney transplantation;
Hematopoietic stem cell transplantation;
Chimerism;
Tolerance
- From:
Chinese Journal of Organ Transplantation
2019;40(5):284-288
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the efficacy of renal transplantation plus hematopoietic stem cell transplantation on inducing immune tolerance and summarize its long-term follow-up outcomes . Methods From 2009 to 2018 ,a total of 11 cases of living related donor kidney transplantation plus hematopoietic stem cell transplantation were performed .Two of them were HLA-matched and the remainder were mismatched for one HLA haplotype . The donor hematopoietic stem cells were mobilized using granulocyte colony-stimulating factor at 5 days pre-transplantation and collected at 1 day pre-operation .The recipients received total lymphoid irradiation for 3 days pre-transplantation and received anti-thymocyte globulin induction during transplantation .The donor hematopoietic stem cells were infused at 2 ,4 and 6 postoperative day .Postoperative regulatory T cells ,chimerism ,B cell activating factor and mixed lymphocyte culture and other parameters were detected and long-term follow-up outcomes tracked .Results The immune tolerance-inducible recipients had a significant increase in activated Treg .One HLA-matched recipient achieved 30％-50％ of chimerism and lost after 6 months .However ,other recipients did not achieve mixed chimerism .The BAFF of recipient spiked sharply after transplantation .Mixed lymphocyte culture indicated that a donor-specific low response was induced .The recipients were followed up for 717 to 3612 days .The first recipient lost renal function and another ten recipients had stable renal function . None of the recipients had myelosuppression or graft-versus-host disease .Allograft biopsy confirmed only one case of mild acute rejection . The dose of immunosuppressive agents was lowered in 5 patients .Conclusions Hematopoietic stem cell transplantation for inducing tolerance is safe during renal transplantation . And chimerism is essential for inducing immune tolerance .
